Introduction: The aim of the study was to evaluate quality of life (QoL) in patients with colorectal cancer during complex treatment using the EORTC QLQ-C30 and QLQ-CR29 questionnaires and to implement routine QoL assessment into our practice.
INTRODUCTION
The growing incidence of colorectal cancer (CRC) is alarming. There are 940 000 new cases diagnosed and a mortality of approximately 500 000 patients annually worldwide [1] . Slovakia remains in the top five countries with the highest incidence and mortality, with 3000 new cases of CRC annually.
CRC is the most frequent malignancy of the gastrointestinal tract. Management of patients with CRC usually combines a multimodal causal treatment with symptomatic therapy and management of side effects [2] . Surgery remains the first treatment option, commonly in combination with neoadjuvant or adjuvant therapy with regards to disease staging and location.
The diagnosis of CRC and the following treatment lead to complex psychomotor, functional, and social impairment, which all affect quality of life (QoL) [3] . Recently, QoL has been considered to be an important component of treatment outcomes. Therefore, research became more focused on psychosomatic and physical well-being [4] .
The QLQ-CR29 questionaire was developed by the EORTC (European Organization for Research and Treatment of Cancer) and is widely used in CRC patients within Europe.
Slovak validation of QLQ-CR29 was completed at the Department of Surgery, Faculty Hospital Trnava in collaboration with EORTC.
The aim of the study was to evaluate QoL in patients with CRC during complex treatment using EORTC QLQ-C30 and QLQ-CR29 questionnaires and to implement routine QoL assessment into practice.
METHODS
The observational study was performed and data are presented using descriptive statistics.
Forty-six patients with CRC were considered eligible for the study. The participation in the trial was voluntary. From a total of 46 patients, 30 (65.2%) patients were included: 20 (67%) men and 10 (33%) women. The average age was 63.7 years with a range of 42 -81 years. In total, 12 (40%) patients were <65 and 18 (60%) were ≥65 years of age. With respect to tumour location, 19 (63%) patients were diagnosed with colon cancer and 11 patients (37%) were diagnosed with rectal cancer. Resection with and without primary stoma formation was performed in 14 (46%) and 5 (17%) patients with colon cancer and in 6 (20%) and 5 (17%) with rectal cancer, respectively (Table 1) . Of 11 (100%) patients with rectal cancer, 9 patients (82%) underwent neoadjuvant chemoradiotherapy (CRT).
QoL questionnaire
Data collection was performed using the EORTC QoL Questionnaire C30 (EORTC QLQ-C30) and the EORTC QLQ-CR29 module at the Department of Surgery, Faculty Hospital Trnava, Slovakia, from May 2014 until April 2015.
All patients with CRC included in the study completed a validated questionnaire in the Slovak language before the initiation of treatment and 1 month after surgery.
Each patient was informed by a clinician about the diagnosis before the first assessment. The patients completed the questionnaire independently with adequate time provided.
The cohort of 46 patients was divided into two groups depending on the tumour location: group 1 included patients with colon cancer and group 2 included patients with rectal cancer (tumour located within 15 cm from linea dentata). Data from the questionnaires were processed using the original software provided by the EORTC.
Statistical analysis
Data were analysed with Statistical software SPSS 22.0.01 using means with standard deviations, a paired t-test and independent t-test. Both groups were compared using an independent t-test. The difference between pre and postoperative QoL outcomes was assessed with a paired t-test. P value ≤ 0.05 was statistically significant.
RESULTS
The comparison of QoL in patients with colon cancer (group 1) and rectal cancer (group 2) is presented in Table 2 (table 2) .
The mean global health status of the cohort was 42.4-43.4 preoperatively and these values increased to 47.7-52.6 one month after the procedure. The patients with colon and rectal cancer differed significantly in the score of buttock pain 1 month after surgery (p=0.001).
A significant difference was also observed between these two groups in mouth dryness (p=0.042), impotence (p=0.035) and sore skin around the anus in patients without stoma (p=0.039).
The outcomes of QoL assessment in patients with CRC stratified by age are presented in Table 3 ( table 3) .
The mean global health status was 30.6-52.8 within the whole cohort. A significant difference between the two age groups was found before the surgery (p=0,007). The score of sexual interest in the group of men differed significantly between these groups before (p=0.020) and after surgery (p=0.007). The fatigue score and the constipation score showed significant differences (p=0.019 and p=0.028, respectively) before the operation. One month after surgery a statistically significant difference was observed in financial difficulties (p=0.020).
The outcomes of QoL evaluation in patients with CRC stratified by gender is shown in Table 4 ( table 4 ).
The mean global health status was preoperatively less than 50.0 in both genders. In the second assessment, 1 month after surgery, the scores for men and women were 47.1 and 58.3, respectively.
A significant difference was found between men and women for body image (p=0.031) and constipation scores (p=0.007) one month after surgery. There was also a significant difference identified for anxiety before surgery (p=0.023).
The evaluation of QoL in patients with and without stoma is presented in Table 5 .
The mean global health status of the studied sample was 36.7-51.7. A significant difference was identified in the physical functioning domain between patients with and without stoma 1 month after surgery (48.0 versus 70.7; p=0.024). A statistically significant difference was found in the fatigue score preoperatively (p=0.045) and 1 month after surgery (p=0.047).
The evaluation of QoL in patients with rectal cancer with and without neoadjuvant CRT is presented in Table 6 .
The mean global health status of patients in the studied cohort was 41.7-50.0. A significant difference between patients who were not treated with neoadjuvant CRT and who completed neoadjuvant treatment was observed in the cognitive functioning domain in the time before surgery (p=0.010). The presence of blood and mucus in stool was more frequent in the group with completed neoadjuvant CRT one month after surgery (p=0.023).
DISCUSSION
CRC represents the most common malignant tumour of the gastrointestinal tract and the second most frequent malignancy after lung cancer in men and breast and ovarian cancer in women [5] .
Loss of health integrity due to presence of CRC or the consequences of its treatment can lead to psychomotor, functional and social disability, which all affect QoL [3] . QoL is an important treatment outcome for overall survival in each individual patient and the concept of QoL gained a specific place in nursing. This is closely related to human needs, health, self-sufficiency, wellbeing, and daily activities [6] . The QoL is influenced by various spheres of life, individual expectations and perception of needs. The importance of particular dimensions can vary during the disease and during life itself [3] .
The variability of symptoms, which depend on tumour localization, the strategy of neoadjuvant treatment, the extent of surgery, and adjuvant therapy can lead to different and individual QoL outcomes in patients with CRC.
The mean global health status score varied in our sample between 42.4-52.6. Statistically significant differences between patients with colon and rectal cancer was found 1 month after surgery for ratings of buttock pain (p=0.001), mouth dryness (p=0.042), impotence (p=0.035) and sore skin around the anus in patients without stoma (p=0.039).
The outcomes from our research differ from Ramsey et al. [7] , who studied 227 patients with CRC and observed high scores of QoL, regardless of tumour localization, staging, and disease duration.
Comorbidities and financial problems were of significantly higher negative impact.
Our findings are, on the other hand, supported by Bernadic and Pechan [8] who reported postoperative QoL correlating with the site of surgery and its complexity. The technique of radical colon cancer resection is less demanding than rectal surgery for multiple reasons such as different mesentery, easier manipulation with the colon and better visualization of constructed anastomosis. 8 The incidence of CRC increases with age. For example, in the U.S.A., the incidence in 45, 55, 65, and 75 years old patients is 10, 30, 90, and 200/100 000 respectively. The peak of CRC incidence is at 65-70 years of age. However, a patient's higher age is not a contraindication for therapeutic interventions including biological treatment. In older patients, the indication is modified by lower levels of fitness, comorbidities, and poor social background [9, 10] .
Marventano states the outcomes of QoL assessment in patients with CRC are controversial regarding age. Some studies showed that QoL improves with age, while the others report a lower QoL in older patients [11] .
In our cohort of CRC patients with ≥65 and <65 years of age, the mean global health score varied between 30.6-52.8 and a statistically significant difference was observed between these groups preoperatively (p=0.007). A significant difference between these groups was also found for sexual interest in subgroups of men preoperatively (p=0.020) and 1 month postoperatively (p=0.007).
Preoperatively, these two groups of ≥65 and <65 years old showed a significant difference in the fatigue score (p=0.019) and constipation score (p=0.028). One month after surgery, there was a statistically significant difference in financial problems (p=0.020).
Similar outcomes were published by Arndt et al., who found a difference between two age groups (≥60 and <60 years old). They found that the group below 60 had more financial problems. A lower score in the physical functioning domain was observed in patients who returned to work after completing treatment [12] . On the other hand, Forsberg et. al. (1996) did not confirm age as an indicator of QoL in patients with CRC [13] .
Gender affects the incidence of CRC. Men have significantly higher incidence of CRC especially in rectal cancer. The ratio between colon and rectal cancer varies in different countries [9] . Natrah et al. performed a study in 2011 on a group of 100 patients in Malaysia. The authors reported a statistically significant difference in cognitive functions between male and female patients. Men showed better cognitive functions in comparison with women. Mean scores of symptoms (fatigue, pain, nausea and vomiting, constipation, diarrhoea, insomnia, shortness of breath, loss of appetite) varied between 4.00 and 20.7. Women showed worse symptoms for pain, fatigue and shortness of breath [14] .
In our research, the gender adjusted mean global health status score varied between 40.8 and 58.3.
A statistically significant difference between men and women was observed one month after the surgical procedure for body image (p=0.031) and constipation (p=0.007). Preoperatively, a significant difference was found for anxiety (p=0.023). Patients with stoma experience a number of losses, such as the loss of ability to control defecation and passage of gas, which can affect normal social life and lead to negative feelings and social and psychological isolation. Patients lose dignity, have feelings of inferiority, and their body image and self-esteem suffer. Many times they are not able to face these situations and are self-disgusted [16] .
In our study, the stoma adjusted mean global health status was 36.7-51.7. In physical functioning, a significant difference was observed 1 month after surgery between patients with and without stoma (p=0.024). Moreover, a statistical difference was found before (p=0.045) and one month after surgery (p=0.047) for the fatigue score. Radiotherapy remains a part of a multimodal approach and is currently applied either as a neoadjuvant or adjuvant treatment [19] . According to Büchler, radiotherapy plays an important role in reduction of local recurrence and palliative therapy of both symptomatic and high risk metastatic lesions [10] .
In our research, the rectal cancer patients with and without complete CRT were compared. The mean global health status of these patients was 41.7-50.0. A significant difference between the above mentioned groups was found in cognitive functioning (p=0.010) and in blood and mucus in stool 1 month after surgery (p=0.023). The limitation of our study was that the first QoL assessment was scheduled relatively shortly after surgery. Nevertheless, our primary aim was to determine the suitability of QoL evaluation in a homogenous group of patients with CRC and implement this method into practice. Thus, we A significant correlation between the QoL score and the type of treatment was found in our study.
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